Lower ICC risk seen in diabetes patients on metformin

12/13/2012 | Healio

Metformin-treated patients with diabetes showed a lower risk of intrahepatic cholangiocarcinoma compared with diabetes patients not taking the drug, researchers reported in Hepatology. Biliary tract disease, cirrhosis, diabetes and smoking were associated with an increased risk of ICC onset, researchers noted.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC